The Angiotensin Converting Enzyme 2 pipeline drugs market research report outlays comprehensive information on the Angiotensin Converting Enzyme 2 targeted therapeutics, complete with analysis by ...

Heart disease is a type of cardiovascular disease that affects the heart’s structure and function. Several different heart ...

Treatment strategies have not been well established for thrombotic microangiopathy associated with malignant hypertension.

Despite being eligible for guideline-directed medical therapy (GDMT), tens of millions of patients across the globe are not ...

Role of the RAAS in the Pathophysiology of Heart Failure ACE inhibitors have no effect on angiotensin II formed by alternate pathways. In contrast, ARBs would be expected to inhibit the biologic ...

Results of a recent study found that glucagon-like peptide-1 receptor agonists (GLP-1RAs) were associated with a lower risk ...

Inconsistent adherence to the guidelines led to delayed heart failure treatment optimization and underutilization of key ...

Discontinuation of RASIs before major noncardiac surgery does not affect postoperative complications and all-cause mortality.

Heart failure is a rapidly growing public health issue that can be difficult to manage on a global scale. But there are tools ...

These findings expose a broad gap in screening for chronic kidney disease that is especially concerning now that there are ...

Heart failure is a rapidly growing public health issue that can be difficult to manage on a global scale. But there are tools ...

Sacubitril and valsartan combination is used to treat chronic heart failure in adults to help reduce the risk of death and ...